Comparison of Safety, Delivery, and Efficacy of Two Oncolytic Herpes Viruses (G207 and NV1020) for Peritoneal Cancer

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700510
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Achieving Systemic Delivery of Oncolytic Viruses

Expert Opinion on Drug Delivery
Pharmaceutical Science
2019English

409. Therapeutic Efficacy of Oncolytic Herpes Virus and Chemotherapy for Treatment of Late-Stage Ovarian Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Comparison of Intravenous Versus Intraperitoneal Administration of Oncolytic Herpes Simplex Virus 1 for Peritoneal Carcinomatosis in Mice

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2008English

Analysis of Genetically Engineered Oncolytic Herpes Simplex Viruses in Human Prostate Cancer Organotypic Cultures

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2009English

Oncolytic Virotherapy: Molecular Targets in Tumor-Selective Replication and Carrier Cell-Mediated Delivery of Oncolytic Viruses

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2008English

Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Phase I/Ii Study of Oncolytic Herpes Simplex Virus NV1020 in Patients With Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Oncolytic Viruses: A Step Into Cancer Immunotherapy

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

New Frontiers in Oncolytic Viruses: Optimizing and Selecting for Virus Strains With Improved Efficacy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy